Inventor profile of:

John Patrick McCook

City:

Frisco, Texas

Country:

United States

Published Applications:

58

Last publication date:

2023-09-14

Top Assignees for applications by John Patrick McCook

The entities that hold a legal rights for patent applications filed by inventor McCook John Patrick:

Recent patent applications by McCook John Patrick

John Patrick McCook from Frisco, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-09-14
US20230285272A1
Human necessities

METHODS OF TREATMENT OF CANCER BY CONTINUOUS INFUSION OF COENZYME Q10

#2 | 2023-06-01
US20230165809A1
Human necessities

INTRAVENOUS FORMULATIONS OF COENZYME Q10 (CoQ10) AND METHODS OF USE THEREOF

#3 | 2023-05-11
US20230147697A1
Human necessities

TOPICAL FORMULATIONS HAVING ENHANCED BIOAVAILABILITY

#4 | 2022-03-31
US20220096399A1
Human necessities

METHODS OF TREATMENT OF SOLID TUMORS USING COENZYME Q10

#5 | 2022-03-17
US20220081720A1
Chemistry; metallurgy

Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)

#6 | 2022-01-27
US20220023317A1
Human necessities

PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D

#7 | 2021-11-11
US20210346291A1
Human necessities

INHALABLE PHARMACEUTICAL COMPOSITIONS

#8 | 2021-10-28
US20210332439A1
Chemistry; metallurgy

METHODS FOR THE DIAGNOSIS OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

#9 | 2021-03-18
US20210077424A1
Human necessities

METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS

#10 | 2021-01-21
US20210015748A1
Human necessities

TOPICAL FORMULATIONS HAVING ENHANCED BIOAVAILABILITY

#11 | 2021-01-07
US20210002725A1
Chemistry; metallurgy

METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCES

#12 | 2020-05-21
US20200157630A1
Chemistry; metallurgy

Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)

#13 | 2020-04-16
US20200113918A1
Human necessities

PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D

#14 | 2020-03-12
US20200078320A1
Human necessities

Method of treating or preventing tumors of the central nervous system

#15 | 2019-01-10
US20190010554A1
Chemistry; metallurgy

METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCES

#16 | 2018-12-27
US20180369381A1
Human necessities

Vitamin D3 and analogs thereof for treating alopecia

#17 | 2018-12-13
US20180355435A1
Chemistry; metallurgy

Methods for treatment of oncological disorders using an epimetabolic shifter (Coenzyme Q10)

#18 | 2018-12-13
US20180353425A1
Human necessities

Methods of treatment of cancer by continuous infusion of coenzyme Q10

#19 | 2018-11-22
US20180334721A1
Chemistry; metallurgy

METHODS FOR THE DIAGNOSIS OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

#20 | 2018-08-16
US20180228703A1
Human necessities

Improved Hyaluronan and Modified-Hyaluronan in Biomedical Applications

#21 | 2017-08-31
US20170246125A1
Human necessities

Method of treating or preventing tumors of the central nervous system

#22 | 2017-08-03
US20170216223A1
Human necessities

METHODS OF TREATMENT OF SOLID TUMORS USING COENZYME Q10

#23 | 2017-05-18
US20170137879A1
Chemistry; metallurgy

METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

#24 | 2016-08-11
US20160228458A1
Human necessities

PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D

#25 | 2016-05-26
US20160145693A1
Chemistry; metallurgy

METHODS FOR THE DIAGNOSIS OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

#26 | 2015-08-20
US20150231091A1
Human necessities

Methods and use of inducing apoptosis in cancer cells

#27 | 2015-06-11
US20150157559A1
Human necessities

Methods of treatment of cancer by continuous infusion of coenzyme Q10

#28 | 2015-01-22
US20150023940A1
Human necessities

Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)

#29 | 2015-01-08
US20150010614A1
Human necessities

METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS

#30 | 2014-08-28
US20140239525A1
Human necessities

INHALABLE PHARMACEUTICAL COMPOSITIONS

#31 | 2014-01-16
US20140017317A1
Human necessities

METHODS OF TREATMENT OF SOLID TUMORS USING COENZYME Q10

#32 | 2013-10-10
US20130266557A1
Human necessities

METHODS FOR TREATMENT OF A SARCOMA USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)

#33 | 2013-08-08
US20130202683A1
Human necessities

Topical formulations having enhanced bioavailability

#34 | 2012-12-20
US20120321698A1
Human necessities

Inhalable pharmaceutical compositions

#35 | 2012-12-06
US20120309086A1
Human necessities

METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS

#36 | 2012-10-25
US20120269867A1
Human necessities

METHODS OF TREATING CENTRAL NERVOUS SYSTEM TUMORS

#37 | 2011-09-22
US20110229554A1
Human necessities

Intravenous formulations of coenzyme Q10 (CoQ10) and methods of use thereof

#38 | 2011-06-16
US20110142914A1
Human necessities

INHALABLE COMPOSITIONS HAVING ENHANCED BIOAVAILABILITY

#39 | 2011-06-09
US20110136231A1
Human necessities

METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS

#40 | 2011-05-26
US20110123987A1
Chemistry; metallurgy

Methods for the diagnosis of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers

#41 | 2011-05-26
US20110123986A1
Chemistry; metallurgy

METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

#42 | 2011-05-12
US20110110914A1
Chemistry; metallurgy

Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers

#43 | 2011-03-17
US20110064747A1
Human necessities

METHODS FOR TREATMENT OF A SARCOMA USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)

#44 | 2011-03-10
US20110059917A1
Human necessities

Vitamin D3 and analogs thereof for treating alopecia

#45 | 2011-02-03
US20110027247A1
Chemistry; metallurgy

METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)

#46 | 2011-01-27
US20110020312A1
Chemistry; metallurgy

METHODS FOR TREATMENT OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

#47 | 2010-09-30
US20100247630A1
Human necessities

Skin treatment compositions containing copper-pigment complexes

#48 | 2010-09-30
US20100247628A1
Human necessities

Skin treatment compositions containing copper-pigment complexes

#49 | 2010-09-30
US20100247591A1
Human necessities

Skin treatment compositions containing copper-pigment complexes

#50 | 2010-08-05
US20100196308A1
Human necessities

VITAMIN D3 AND ANALOGS THEREOF FOR ALLEVIATING SIDE EFFECTS ASSOCIATED WITH CHEMOTHERAPY

#51 | 2008-12-25
US20080317836A1
Human necessities

Topical compositions for anti-aging skin treatment

#52 | 2008-12-04
US20080299155A1
Human necessities

Color cosmetic compositions for topical anti-aging skin treatment

#53 | 2008-09-25
US20080233183A1
Human necessities

Topical formulations having enhanced bioavailability

#54 | 2007-06-28
US20070148224A1
Human necessities

Skin treatment compositions containing copper-pigment complexes

#55 | 2007-06-28
US20070148223A1
Human necessities

Skin treatment compositions containing copper-pigment complexes

#56 | 2007-06-28
US20070148222A1
Human necessities

Skin treatment compositions containing copper-pigment complexes

#57 | 2006-08-10
US20060177398A1
Human necessities

Sunless tanning products and processes

#58 | 2006-06-22
US20060134027A1
Human necessities

Sunless tanning products and processes

InventorID:

376557 ⎘